Back
Regeneron Pharmaceuticals, Inc. Vs. Nebius Group NV Industry Stock Comparison
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$767.87
Seasonality Move:
12.13%
Sell
42
NBIS
Nebius Group NV
Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $767.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $89.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 142.35 | Buy |
| Relative Strength Index (14 RSI): | 64.22 | Buy |
| Chaikin Money Flow: | 1264020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (712.01 - 765.19) | Buy |
| Bollinger Bands (100): | (552.57 - 698.59) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.05 | Sell |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | 13904832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.34 - 98.02) | Sell |
| Bollinger Bands (100): | (72.32 - 115.66) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 747.47 | Buy |
| 20-day SMA: | 745.1 | Buy |
| 50-day SMA: | 678.03 | Buy |
| 200-day SMA: | 600.91 | Buy |
| 8-day EMA: | 400.86 | Buy |
| 20-day EMA: | 196.11 | Buy |
| 50-day EMA: | 85.47 | Buy |
| 200-day EMA: | 22.33 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.08 | Buy |
| 20-day SMA: | 91.37 | Sell |
| 50-day SMA: | 102.98 | Sell |
| 200-day SMA: | 65.21 | Buy |
| 8-day EMA: | 85.42 | Buy |
| 20-day EMA: | 90.53 | Sell |
| 50-day EMA: | 95.55 | Sell |
| 200-day EMA: | 73.6 | Buy |
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||